Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Epigenetic and 3D genome reprogramming during the aging of human hippocampus.

Autor: Zemke NR; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA.; Center for Epigenomics, University of California, San Diego School of Medicine; La Jolla, CA, USA., Lee S; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA., Mamde S; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA., Yang B; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA.; Center for Epigenomics, University of California, San Diego School of Medicine; La Jolla, CA, USA., Berchtold N; Department of Anatomy and Neurobiology, University of California, Irvine School of Medicine; Irvine, CA, USA.; Immunis Inc, 18301 Von Karman Ave; Irvine, CA, USA., Maximiliano Garduño B; Department of Anatomy and Neurobiology, University of California, Irvine School of Medicine; Irvine, CA, USA., Indralingam HS; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA.; Center for Epigenomics, University of California, San Diego School of Medicine; La Jolla, CA, USA., Bartosik WM; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA.; Center for Epigenomics, University of California, San Diego School of Medicine; La Jolla, CA, USA., Lau PK; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA.; Center for Epigenomics, University of California, San Diego School of Medicine; La Jolla, CA, USA., Dong K; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA.; Center for Epigenomics, University of California, San Diego School of Medicine; La Jolla, CA, USA., Yang A; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA., Tani Y; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA., Chen C; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA., Zeng Q; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA., Ajith V; Department of Anatomy and Neurobiology, University of California, Irvine School of Medicine; Irvine, CA, USA., Tong L; Department of Anatomy and Neurobiology, University of California, Irvine School of Medicine; Irvine, CA, USA., Seng C; Department of Genetics, The Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine; St. Louis, MO, USA., Li D; Department of Genetics, The Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine; St. Louis, MO, USA., Wang T; Department of Genetics, The Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine; St. Louis, MO, USA.; McDonnell Genome Institute, Washington University School of Medicine; St. Louis, MO, USA., Xu X; Department of Anatomy and Neurobiology, University of California, Irvine School of Medicine; Irvine, CA, USA.; The Center for Neural Circuit Mapping, University of California; Irvine, CA, USA., Ren B; Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine; La Jolla, CA, USA.; Center for Epigenomics, University of California, San Diego School of Medicine; La Jolla, CA, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.

Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.

Autor: Hoon SN; Medical Oncology Department, St John of God Midland, Perth, Australia.; Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia., Lau PK; Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia.; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Australia., White AM; Murdoch Community Hospice, St John of God Hospital Murdoch, Perth, Australia.; Palliative Care Department, Royal Perth Hospital, Perth, Australia., Bulsara MK; Institute for Health Research, University of Notre Dame Australia, Fremantle, Australia.; School of Population and Global Health, The University of Western Australia, Perth, Australia.; Division of Surgery and Interventional Science, University College London, London, UK., Banks PD; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Australia.; Medical Oncology Department, University Hospital Geelong, Geelong, Australia., Redfern AD; School of Medicine, University of Western Australia, Perth, Australia.; Medical Oncology Department, Fiona Stanley Hospital, Perth, Australia.

Publikováno v: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2021 May 26; Vol. 5. Cochrane AN: CD011220. Date of Electronic Publication: 2021 May 26.